Quick Answer
InspireMD, Inc. reported Cash and Equivalents of $8.94 million for fiscal year 2025.
InspireMD, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $8.94M | -52.7% |
| 2024 | $18.92M | +96.2% |
| 2023 | $9.64M | +108.1% |
| 2022 | $4.63M | -61.4% |
| 2021 | $12.00M | -5.1% |
| 2020 | $12.64M | +129.3% |
| 2019 | $5.51M | -41.2% |
| 2018 | $9.38M | +152.9% |
| 2017 | $3.71M | -50.6% |
| 2016 | $7.52M | +130.8% |
| 2015 | $3.26M | -48.3% |
| 2014 | $6.30M | -64.1% |
| 2013 | $17.54M | +18.3% |
| 2013 | $14.82M | +44.1% |
| 2012 | $10.28M | +101.9% |
| 2011 | $5.09M | -36.9% |
| 2011 | $8.07M | +1168.9% |
| 2010 | $636.0K | +69.1% |
| 2009 | $376.0K | -76.1% |
| 2008 | $1.57M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $63.40M | +300.8% | +450.9% |
| June 30, 2025 | $11.51M | -59.5% | -7.1% |
| March 31, 2025 | $12.38M | +31.9% | -34.5% |
| December 31, 2024 | $18.92M | +96.2% | +19.6% |
| September 30, 2024 | $15.82M | +14.3% | -44.3% |
| June 30, 2024 | $28.39M | +145.9% | +202.3% |
| March 31, 2024 | $9.39M | +122.1% | -2.6% |
| December 31, 2023 | $9.64M | +108.1% | -30.3% |
- InspireMD, Inc. showed a decrease of -52.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, InspireMD, Inc.’s cash and equivalents has grown by 469.0% (from $1.57 million to $8.94 million).
- The most recent figure is from InspireMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: